Dr Lori Laffel is Chief of the Pediatric, Adolescent and Young Adult Section; Senior Investigator/Head of the Section on Clinical, Behavioral and Outcomes Research; and Professor of Pediatrics at the Joslin Diabetes Center, Harvard Medical School. She has published over 300 articles in peer-reviewed journals. She has been on the Advisory Board of the International Society of Pediatric and Adolescent Diabetes (ISPAD) and a member of the Clinical and Research Advisory Committees for JDRF. Dr. Laffel is involved with the American Diabetes Association (ADA), as a member of the Boston Leadership Board, past member of the National Board of Directors, Committee for Professional Practice Guidelines, co-chair on the Working Group on Transition, and past chair of ADA’s Youth Strategies Committee. She is a member of ADA’s Pathway Mentor Advisory Program. Dr. Laffel is a global editor for the journal Diabetic Medicine. Her research focuses on understanding and overcoming challenges to diabetes self-management in order to improve glycemic control and other biomedical and psychosocial outcomes. Her research also aims to evaluate new diabetes technologies and optimize their use across the life span, including continuous glucose monitors (CGM) and automated insulin delivery systems. She is recipient of many NIH and foundation-funded grants. She received ADA’s 2015 Outstanding Physician-Clinician Award, the Greater Boston Chamber of Commerce 2016 Pinnacle Award, and the 2016 University of Miami School of Medicine Hall-of-Fame Award.